On April 2, 2025, President Donald Trump imposed a 10% tariff on all imports, with India facing a 26% tariff.
The 26% tariff is expected to impact Indian industries, including electronics, gems and jewelry, textiles, and automotive components.
However, the pharmaceutical industry, exporting $9 billion annually to the U.S., is exempt from the tariffs.
India is proactively engaging in negotiations to mitigate the effects, proposing tariff reductions on U.S. agricultural products and considering eliminating import taxes on U.S. liquefied natural gas (LNG).